Consumer Protection Grants

509 federal consumer protection grants — 9 currently open. Filter open grants →

Exploring the use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making (U01) Clinical Trials Optional

Archived

Food and Drug Administration

Incorporating cost effectiveness & societal outcomes into FDA opioids model (U01)

Archived

Food and Drug Administration

Smoking Machine Adaptor Design Project for ENDS, Cigars, and Heated Tobacco Products

Archived

Food and Drug Administration

Drug Development Science Support (U01)

Archived

Food and Drug Administration

CBER FY20 FOA for AAV vector manufacturing for diseases affecting very small populations (R01) Clinical Trial Not Allowed

Archived

Food and Drug Administration

Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability

Archived

Food and Drug Administration

PBPK Models to Aid the Development of Generic Dermatological Products

Archived

Food and Drug Administration

PBPK Models of Oral Absorption to Simulate the Results of Bioequivalence Studies

Archived

Food and Drug Administration

Implementation of the National Evaluation System for Health Technology (NEST) Coordinating Center (CC)

Archived

Food and Drug Administration

CFD Models to aid the development of generic inhalation products

Archived

Food and Drug Administration

Analgesic, Anesthetic and Addiction Clinical Trials Innovations, Opportunities, and Networks (ACTTION)

Archived

Food and Drug Administration

SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots) Public-Private Partnership

Archived

Food and Drug Administration

Quantify the expression of metabolizing enzymes and transporter proteins in lung, eye and skin tissue in relevant animal models and humans

Archived

Food and Drug Administration

Impulse Oscillometry Endpoint Sensitivity to Regional Lung Function Changes using Computational Fluid Dynamics (CFD)

Archived

Food and Drug Administration

Dermal Physiologically-Based Pharmacokinetic (PBPK) Models Accounting for the Absorption and Evaporation of Vehicle/Co-Solvent Following the Application of Generic Dermatological Products

Archived

Food and Drug Administration

Expanding the Opioids System Model to more comprehensively incorporate fentanyl, stimulants use, polysubstance use and associated outcomes.

Archived

Food and Drug Administration

Development of a model selection method for population pharmacokinetics analysis by deep-learning based reinforcement learning

Archived

Food and Drug Administration

Drug Development Tools Research Grants (U01 Clinical Trial Optional)

Archived

Food and Drug Administration

Minor Use Minor Species Development of Drugs (R01) Clinical Trials Not Allowed

Archived

Food and Drug Administration

Integrated Pathogen Reduction Technologies for whole blood and blood components for transfusion (R01) Clinical Trials Not Allowed

Archived

Food and Drug Administration

Closes: Jul 6, 2021